// App-Quantinova.ai

TCT-61 : Safety and Efficacy of the Resorbable Magnesium Scaffold Magmaris in a Real-World Setting—24-Month Follow-up of the Full Cohort (2,066 subjects) of the BIOSOLVE-IV Registry

Researchers

Presenter

  • Johan Bennett

Principal Investigators

  • Adrian Wlodarczak

  • Piero Montorsi

  • Jan Torzewski

  • Gregory Starmer

  • Thomas Buck

  • Michael Haude

  • Marco Moccetti

  • Michael Kang-Yin Lee

  • Stefan Verheye

Medical Centers

  • Rheinland Klinikum Neuss, Lukaskrankenhaus, Neuss, Germany

  • ZNA Middelheim, Antwerp, Belgium

  • Klinikum Westfahlen Knappschaftskrankenhaus, Dortmund, Germany

  • Cardiocentro Ticino, Lugano, Switzerland

  • Centro Cardiologico Monzino, IRCCS, Milan, Italy

  • Queen Elizabeth Hospital, Hong Kong, China

  • Klinikum Kempten Oberallgäu, Oberallgäu, Germany

  • Universitair Ziekenhuis Leuven, Leuven, Belgium

  • Cairns Hospital, Cairns, Queensland, Australia

  • Copper Health Center, Lubin, Poland

Locations

  • Germany

  • Belgium

  • Switzerland

  • Italy

  • China

  • Australia

  • Poland

Companies

  • N/A

Study Components

Therapeutic Area

  • Pulmonary/Respiratory Diseases

  • Blood/haematological Diseases

  • Cardiovascular (CVS)

Disease

  • Myocardial infarction

  • Venous thrombosis

Biomarkers

  • N/A

Drug/Treatment

  • sirolimus

  • Rapacan

Outcome

  • N/A

Study Design

  • Single Arm

  • Multinational

  • Multicenteric

  • Prospective

  • Cohort

Phase

  • NA

Study Id's

  • N/A

Sponsors

  • N/A

Result

  • N/A

Copyright © 2026. QuantiNova All rights reserved